Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P120024/S014

activL Artificial Disc

Highridge Medical, LLC · Decision date Jan 29, 2026

FDA DECISIONP120024/S014

What did the FDA approve?

FDA records P120024/S014 as a supplement to PMA P120024, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Jan 29, 2026.

FDA approval order statement

Approval of the Olive Branch Distribution Center (FEI 3016050940) as an additional facility for conducting incoming product inspections, Device History Record (DHR) documentation review, and release of finished goods into inventory for distribution of the subject device to the United States market.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Orthopedic
Decision date
Jan 29, 2026
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P120024/S014
Regulatory pathway
PMA supplement
Product code
MJO
Decision code
APPR
Decision date
Jan 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, intervertebral disc.

Product code
MJO
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P120024/S014 received

    Application receipt date recorded by FDA.

  2. P120024/S014 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P120024. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

Other records with product code MJO

Product / regulatory recordCompanyPathwayDecision dateSource
Spineart USA, Inc.PMA supplementSep 22, 2026FDA
Synergy DiscP250028/S003
Synergy Spine Solutions, Inc.PMA supplementSep 17, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
prodisc C NovaP070001/S031
Centinel Spine, LLCPMA supplementSep 9, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Highridge Medical, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
10225 Westmoor Dr., Westminister, CO, 80021

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records